ER+/HER2+ Metastatic Breast Cancer
2 Mga view
• 07/03/23
0
0
I-embed
administrator
Mga subscriber
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento